No profile data available.
BrainsWay Ltd. (BWAY) is a healthcare company in the targeted healthcare equipment industry, based in Jerusalem, Israel, with about 129 full-time employees.
It reported revenue of $52.23 million for fiscal year 2025, up 27.3% from fiscal year 2024, and net income of $7.63 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $17.11 million, up 35.4% from a year before. U.S. was its largest region in fiscal year 2025, with 85% of revenue. Its market capitalization was $473.78 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
BrainsWay reported $52.23 million in revenue for fiscal year 2025, up 27.3% from $41.02 million in fiscal year 2024. In Q2 2026 revenue was $17.11 million.
U.S.: 85% of revenue by region in fiscal year 2025, followed by Other (15%).
$473.78 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Ceribell, Inc. (CBLL), Tactile Systems Technology, Inc. (TCMD), Sight Sciences, Inc. (SGHT), NeuroPace, Inc. (NPCE).